A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal cancer. Patients in a UK-led trial who received just nine weeks of pembrolizumab prior to surgery have remained cancer-free nearly three years later—an outcome that challenges the standard approach of surgery followed by months of chemotherapy.
A major 10-year clinical trial is turning one of the world’s most common knee surgeries on its head. Researchers found that trimming a damaged meniscus—a procedure long believed to relieve pain—offers no real benefit over placebo surgery. Even more surprising, patients who had the operation actually fared worse over time, with more symptoms, poorer function, faster progression of osteoarthritis, a
A chaotic sleep schedule in your 40s might be quietly setting the stage for heart trouble later. Researchers tracking thousands of people for over a decade found that those with highly inconsistent bedtimes—especially when they slept less than eight hours—faced about double the risk of serious cardiovascular events like heart attacks or strokes. Interestingly, it wasn’t when people woke up that ma
In this edition of STAT Health Tech: A high-profile study on AI's diagnostic capabilities, role of telehealth in abortion access, and an Epic lawsuit.
The pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over access and pricing.
A key GOP lawmaker is broadening the party's efforts to combat health care fraud.
Cytokinetics' Myqorzo's trial results, Johnson & Johnson's IBD therapy, and more biotech news from The Readout
Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue from within, reducing inflammation and jumpstarting healing. In animal studies, it successfully treated heart attack damage and even showed promise for conditions like traumatic brain injury and pulmonary hypertension. Unlike earlier approaches that required direct injectio
GLP-1 weight-loss drugs like Ozempic and Wegovy are often celebrated as game-changing solutions—but new research reveals a surprising social twist. People who lose weight using these medications may actually face more judgment than those who lose weight through diet and exercise—or even those who don’t lose weight at all. The stigma seems rooted in a perception that these drugs are an “easy way ou
HHS Secretary Robert F. Kennedy Jr. announced initiatives to rein in prescribing of SSRIs, the most widely used antidepressants
The latest on the abortion pill, paternal deaths, and more health news from Morning Rounds
With a better-than-expected first quarter in the books, Pfizer—continuing to grapple with the post-pandemic overhang from its COVID-19 franchise—is sticking with the sales forecast it set earlier this year, raising questions from at least one analyst about whether it could have lifted its outlook.
Novartis is continuing its multiyear overhaul with new plans to shutter its production facility in Wehr, Germany, by 2028. The move, announced Tuesday, will eliminate about 220 jobs, according to Novartis.
The German vaccine maker plans to wind down operations at a handful of its sites in Germany plus one in Singapore, putting as many as 1,860 jobs on the chopping block.
Fresh off gaining an FDA expansion for Auvelity as a treatment for agitation associated with Alzheimer’s disease, Axsome Therapeutics has projected peak sales for the non-antipsychotic drug to reach $8 billion.
Sanofi is supercharging its artificial intelligence capabilities. The French pharma is investing $294 million to expand its global AI center of excellence in Toronto, kicking off a scale-up of the digital infrastructure it built at the Canadian hub four years ago.
A closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD patients.
A new study suggests travel could be a surprisingly powerful anti-aging tool. By viewing tourism through the lens of entropy, researchers found that positive travel experiences may help the body stay balanced and resilient. Activities like exploring new places, staying active, and connecting with others can boost immunity, metabolism, and stress recovery. However, stressful or unsafe travel could
France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.
The 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E. Colón.